Valuation: LifeTech Scientific Corporation

Market Cap 5.99B 7.05B 899M 804M 743M 674M 1.26B 85.34B 1.28B 8.94B 3.54B 44.76B 3.37B 3.3B 141B P/E 2024
25.7x
P/E 2025 42.5x
Enterprise Value 4.85B 5.71B 728M 651M 601M 545M 1.02B 69.07B 1.03B 7.24B 2.86B 36.22B 2.73B 2.67B 114B EV / Sales 2024
3.74x
EV / Sales 2025 3.91x
Free-Float
77.55%
Yield 2024 *
-
Yield 2025 -
1 day+0.33%
1 week+8.57%
Current month+8.96%
1 month+12.18%
3 months+7.04%
6 months-20.83%
Current year-2.56%
1 week 1.4
Extreme 1.405
1.58
1 month 1.26
Extreme 1.255
1.58
Current year 1.26
Extreme 1.255
2.38
1 year 1.26
Extreme 1.255
2.38
3 years 1.24
Extreme 1.24
2.63
5 years 1.24
Extreme 1.24
4.36
10 years 1.13
Extreme 1.13
5.98
Manager TitleAgeSince
Chief Executive Officer 56 01/03/2015
Director of Finance/CFO 55 31/08/2010
Corporate Officer/Principal - 21/05/2026
Director TitleAgeSince
Chairman 56 16/08/2006
Director/Board Member 63 31/03/2014
Director/Board Member 68 31/03/2014
Date Insider Type Main position Quantity % Market Cap. Importance
07/05/26 Other

Director

16,000,000 0.3454%
07/05/26 Other

Chief Financial Officer

50,000,000 1.0795%
07/05/26 Other

Executive/Senior Manager

21,800,000 0.4707%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%+8.57%-26.92%-33.91% 895M
-0.40%-3.25%+18.80%+45.11% 250B
+0.33%-0.43%+5.69%+11.99% 162B
+1.90%+5.71%-14.18%+69.45% 154B
-0.70%+3.51%-56.00%-8.71% 66.68B
+0.24%+2.47%-15.16%-9.00% 52.08B
+0.15%+3.20%+11.42%+61.21% 52.22B
-1.13%+1.10%+15.92%+28.20% 51.93B
-0.47%-1.41%+18.65%+58.45% 49.02B
-0.42%+2.14%+30.11%+78.86% 44.76B
Average -0.02%+2.17%-1.17%+30.16% 88.32B
Weighted average by Cap. +0.13%+0.55%+2.92%+38.36%

Financials

2024 2025
Net sales 1.3B 1.53B 196M 175M 162M 147M 274M 18.58B 278M 1.95B 770M 9.74B 734M 719M 30.69B 1.37B 1.61B 206M 184M 170M 154M 287M 19.52B 292M 2.05B 809M 10.24B 772M 755M 32.25B
Net income 222M 262M 33.39M 29.86M 27.58M 25.01M 46.67M 3.17B 47.47M 332M 131M 1.66B 125M 123M 5.24B 148M 174M 22.19M 19.85M 18.34M 16.63M 31.02M 2.11B 31.56M 221M 87.32M 1.1B 83.28M 81.51M 3.48B
Net Debt -1.18B -1.39B -177M -158M -146M -132M -247M -16.77B -251M -1.76B -695M -8.8B -663M -649M -27.71B -1.14B -1.34B -171M -153M -142M -128M -240M -16.28B -244M -1.71B -675M -8.54B -643M -630M -26.89B
Projected Income Statement - Annual - LifeTech Scientific Corporation
Logo LifeTech Scientific Corporation
LifeTech Scientific Corp is an investment holding company primarily engaged in the development, manufacture and trading of interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company mainly operates its business through three segments. The Structural Heart Diseases Business segment is engaged in trading, manufacture, research and development of devices related to structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in trading, manufacture, research and development of devices related to peripheral vascular diseases. The Cardiac Pacing and Electrophysiology Business segment is engaged in trading, manufacture, research and development of devices related to cardiac pacing and electrophysiology. The Company conducts its business in the domestic and overseas markets.
Employees
1,254
Date Price Change Volume
23/10/26 HK$1.520 +0.33% 21,816,000
22/10/26 HK$1.515 -1.94% 24,576,000
21/10/26 HK$1.545 +5.10% 45,026,000
20/10/26 HK$1.470 +3.89% 28,484,000
16/10/26 HK$1.415 +1.07% 13,416,000
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - LifeTech Scientific Corporation

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - LifeTech Scientific Corporation
  1. Stock Market
  2. Stocks
  3. 1302 Stock